Hennion & Walsh Asset Management’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.56M | Buy |
5,439
+1,142
| +27% | +$328K | 0.06% | 366 |
|
|
2025
Q1 | $1.32M | Buy |
4,297
+1,970
| +85% | +$607K | 0.06% | 401 |
|
|
2024
Q4 | $821K | Sell |
2,327
-1,959
| -46% | -$691K | 0.04% | 511 |
|
|
2024
Q3 | $1.54M | Buy |
4,286
+1,023
| +31% | +$367K | 0.07% | 352 |
|
|
2024
Q2 | $1.04M | Sell |
3,263
-28
| -0.9% | -$8.92K | 0.05% | 412 |
|
|
2024
Q1 | $756K | Buy |
3,291
+413
| +14% | +$94.9K | 0.04% | 483 |
|
|
2023
Q4 | $633K | Sell |
2,878
-41
| -1% | -$9.02K | 0.04% | 514 |
|
|
2023
Q3 | $659K | Buy |
2,919
+210
| +8% | +$47.4K | 0.04% | 452 |
|
|
2023
Q2 | $598K | Buy |
2,709
+55
| +2% | +$12.1K | 0.04% | 466 |
|
|
2023
Q1 | $594K | Sell |
2,654
-2,488
| -48% | -$557K | 0.04% | 473 |
|
|
2022
Q4 | $1.43M | Sell |
5,142
-14,314
| -74% | -$3.98M | 0.09% | 265 |
|
|
2022
Q3 | $4.07M | Sell |
19,456
-1,265
| -6% | -$265K | 0.27% | 91 |
|
|
2022
Q2 | $4.88M | Sell |
20,721
-17,372
| -46% | -$4.09M | 0.3% | 78 |
|
|
2022
Q1 | $6.83M | Sell |
38,093
-1,467
| -4% | -$263K | 0.36% | 64 |
|
|
2021
Q4 | $8.55M | Sell |
39,560
-2,910
| -7% | -$629K | 0.42% | 53 |
|
|
2021
Q3 | $7.84M | Sell |
42,470
-598
| -1% | -$110K | 0.41% | 54 |
|
|
2021
Q2 | $7.73M | Buy |
43,068
+4,996
| +13% | +$896K | 0.41% | 50 |
|
|
2021
Q1 | $6.37M | Buy |
+38,072
| New | +$6.37M | 0.38% | 63 |
|